Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975

Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor

Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein

Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., & Ito, H. (1988) · Nature · doi:10.1038/331530a0 · Cited by 1,083

Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction

Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,066

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

Ponte, P. A., Gonzalez‐DeWhitt, P. A., Schilling, J., Miller, J., Hsu, D. K., Greenberg, B., Davis, K. L., Wallace, W., Lieberburg, I. M., Fuller, F. H., et al. (1988) · Nature · doi:10.1038/331525a0 · Cited by 1,050

Novel insights into protein misfolding diseases revealed by ion mobility‐mass spectrometry

Williams, D. M., & Pukala, T. L. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21358 · Cited by 45

Melanosomal formation of PMEL core amyloid is driven by aromatic residues

Hee, J. S., Mitchell, S. M., Liu, X., & Leonhardt, R. M. (2017) · Scientific Reports · doi:10.1038/srep44064 · Cited by 42

ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans

Griffin, E. F., Scopel, S. E., Stephen, C. A., Holzhauer, A. C., Vaji, M. A., Tuckey, R. A., Berkowitz, L. A., Caldwell, K. A., & Caldwell, G. A. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.037218 · Cited by 48

Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer’s disease

Izco, M., Martinez, P. M., Corrales, A., Fandos, N., García-Cerro, S., Insua, D., Montañés, M., Pérez‐Grijalba, V., Rueda, N., Vidal, V., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.003 · Cited by 46

Alzheimer’s β-Amyloid: Insights into Fibril Formation and Structure from Congo Red Binding

Inouye, H., & Kirschner, D. A. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_10 · Cited by 43

IL-1 and anti-inflammatory drugs modulate A β cytotoxicity in PC12 cells

Fágárásan, M. O., & Aisen, P. S. S. (1996) · Brain Research · doi:10.1016/0006-8993(96)00259-4 · Cited by 43

β-Amyloid(25–35) induces the production of interleukin-8 from human monocytes

Meda, L., Bonaiuto, C., Szendrei, G. I., Ceska, M., Rossi, F., & Cassatella, M. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00021-s · Cited by 44

Molecular and Cellular Basis for Anti-Amyloid Therapy in Alzheimer Disease

Gandy, S., Martins, R. N., & Buxbaum, J. D. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200310000-00011 · Cited by 41

Controlling Amyloid‐β Peptide(1–42) Oligomerization and Toxicity by Fluorinated Nanoparticles

Saraiva, A. M., Cardoso, I., Pereira, M. D. C., Coelho, M. A. N., Saraiva, M. J., Möhwald, H., & Brezesinski, G. (2010) · ChemBioChem · doi:10.1002/cbic.201000237 · Cited by 41

Online, High-Pressure Digestion System for Protein Characterization by Hydrogen/Deuterium Exchange and Mass Spectrometry

Jones, L. M., Zhang, H., Vidavsky, I., & Gross, M. L. (2010) · Analytical Chemistry · doi:10.1021/ac902477u · Cited by 41

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

Bros, P., Delatour, V., Vialaret, J., Lalère, B., Barthélemy, N. R., Gabelle, A., Lehmann, S., & Hirtz, C. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1048 · Cited by 41

Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis

Azria, D., Blanquer, S., Verdier, J., & Belamie, E. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01599b · Cited by 43

Aβ under stress: the effects of acidosis, Cu 2+ -binding, and oxidation on amyloid β-peptide dimers

Liao, Q., Owen, M. C., Bali, S., Barz, B., & Strodel, B. (2018) · Chemical Communications · doi:10.1039/c8cc02263a · Cited by 42

Age-related loss of phospholipid asymmetry in APP /APP x PS-1 /PS-1 human double mutant knock-in mice: Relevance to Alzheimer disease

Lange, M. L. B., Clair, D. K. S., Markesbery, W. R., Studzinski, C. M., Murphy, M. P., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.004 · Cited by 41

Differential regulation by β-amyloid peptides of intracellular free Ca2+ concentration in cultured rat microglia

Korotzer, A. R., Whittemore, E. R., & Cotman, C. W. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90006-3 · Cited by 42

From Soluble A β to Progressive A β Aggregation: Could Prion‐Like Templated Misfolding Play a Role?

Eisele, Y. S. (2013) · Brain Pathology · doi:10.1111/bpa.12049 · Cited by 43

DMXB (GTS‐21) ameliorates the cognitive deficits in beta amyloid injected mice through preventing the dysfunction of alpha7 nicotinic receptor

Chen, L., Wang, H., Zhang, Z., Li, Z., He, D., Sokabe, M., & Chen, L. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22345 · Cited by 40

Morphological Development of β(1-40) Amyloid Fibrils

Blackley, H. K. L., Patel, N., Davies, M. C., Roberts, C. J., Tendler, S. J. B., Wilkinson, M. J., & Williams, P. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7114 · Cited by 39

Controlled Production of Amyloid β Peptide from a Photo‐Triggered, Water‐Soluble Precursor “Click Peptide“

Taniguchi, A., Skwarczyński, M., Sohma, Y., Okada, T., Ikeda, K., Prakash, H., Mukai, H., Hayashi, Y., Kimura, T., Hirota, S., et al. (2008) · ChemBioChem · doi:10.1002/cbic.200800503 · Cited by 39

p53 Is Regulated by and Regulates Members of the γ-Secretase Complex

Checler, F., Dunys, J., Pardossi‐Piquard, R., & da Costa, C. A. (2010) · Neurodegenerative Diseases · doi:10.1159/000283483 · Cited by 39

Complement C1q expression induced by Aβ in rat hippocampal organotypic slice cultures

Fan, R., & Tenner, A. J. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.023 · Cited by 39

JLK isocoumarin inhibitors: Selective γ‐secretase inhibitors that do not interfere with notch pathway in vitro or in vivo

Petit-Paitel, A., Pasini, A., da Costa, C. A., Ayral, E., Hernandez, J., Dumanchin‐Njock, C., Phiel, C. J., Marambaud, P., Wilk, S., Farzan, M., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10747 · Cited by 39

Alzheimer's β-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner

Bergamaschini, L. C., Canziani, S., Bottasso, B., Cugno, M., Braidotti, P., & Agostoni, A. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00835.x · Cited by 39

Dityrosine Cross-Linked Aβ Peptides: Fibrillar β-Structure in Aβ(1-40) Is Conducive to Formation of Dityrosine Cross-Links but a Dityrosine Cross-Link in Aβ(8-14) Does Not Induce β-Structure

Yoburn, J. C., Tian, W., Brower, J. O., Nowick, J. S., Glabe, C. G., & Vranken, D. L. V. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025666g · Cited by 39

Simulations of monomeric amyloid β-peptide (1–40) with varying solution conditions and oxidation state of Met35: Implications for aggregation

Brown, A. M., Lemkul, J. A., Schaum, N., & Bevan, D. R. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.01.002 · Cited by 39

Arginine and Disordered Amyloid-β Peptide Structures: Molecular Level Insights into the Toxicity in Alzheimer’s Disease

Coskuner‐Weber, O., & Wise-Scira, O. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001389 · Cited by 38

New Insights Into Autophagy Dysfunction Related to Amyloid Beta Toxicity and Neuropathology in Alzheimer's Disease

Ntsapi, C., Lumkwana, D., Swart, C., du Toit, A., & Loos, B. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.002 · Cited by 39

Nanoscale Terahertz Monitoring on Multiphase Dynamic Assembly of Nanoparticles under Aqueous Environment

Yu, E., Lee, S., Lee, G., Park, Q., Chung, A. J., Seo, M., & Ryu, Y. (2021) · Advanced Science · doi:10.1002/advs.202004826 · Cited by 38

Advances on the Understanding of the Origins of Synaptic Pathology in AD

Lacor, P. N. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 40

Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment

Woltjer, R. L., McMahan, W., Milatović, D., Kjerulf, J. D., Shie, F., Rung, L. G., Montine, K. S., & Montine, T. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.003 · Cited by 38

Alzheimer's amyloid-beta peptide inhibits sodium/calcium exchange measured in rat and human brain plasma membrane vesicles

Wu, A., D’Errico, C., Hatem, L., & Colvin, R. A. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00053-5 · Cited by 38

Calcium Homeostasis and Free Radical Metabolism as Convergence Points in the Pathophysiology of Dementia

Mattson, M. P., Furukawa, K., Bruce‐Keller, A. J., Mark, R. J., & Blanc, E. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_8 · Cited by 38

Eight-residue Aβ peptides inhibit the aggregation and enzymatic activity of Aβ42

Matsunaga, Y., Fujii, A., Awasthi, A., Yokotani, J., Takakura, T., & Yamada, T. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.013 · Cited by 38

Overcoming synthetic Aβ peptide aging: a new approach to an age-old problem

Manzoni, C., Colombo, L., Messa, M., Cagnotto, A., Cantú, L., Favero, E. D., & Salmona, M. (2009) · Amyloid · doi:10.1080/13506120902879848 · Cited by 37

Amyloid-β peptide (1–42) aggregation induced by copper ions under acidic conditions

Bin, Y., Li, X., He, Y., Chen, S., & Xiang, J. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt044 · Cited by 36

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, PF ‐06648671, on CSF Amyloid‐β Peptides in Randomized Phase I Studies

Ahn, J. E., Carrieri, C., Cruz, F. D., Fullerton, T., Hajós‐Korcsok, É., He, P., Kantaridis, C., Leurent, C., Liu, R., Mancuso, J. Y., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1570 · Cited by 38

Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils

Siddiqi, M. K., Malik, S., Majid, N., Alam, P., & Khan, R. H. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.06.001 · Cited by 38

β-Amyloid1-42, HIV-1Ba-L (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A

Kurapati, K. R. V., Samikkannu, T., Atluri, V. S. R., Kaftanovskaya, E. M., Yndart, A., & Nair, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112818 · Cited by 37

‘O-Acyl isopeptide method’ for the efficient preparation of amyloid β peptide 1–42 mutants

Sohma, Y., Chiyomori, Y., Kimura, M., Fukao, F., Taniguchi, A., Hayashi, Y., Kimura, T., & Kiso, Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.037 · Cited by 38

The region 1–11 of Alzheimer amyloid-β is critical for activation of contact-kinin system

Bergamaschini, L. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00174-3 · Cited by 38

Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3

Fekete, C., Vastagh, C., Dénes, Á., Hrabovszky, E., Nyíri, G., Kalló, I., Liposits, Z., & Sárvári, M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.046 · Cited by 39

γ-Secretase Cleavage Is Distinct from Endoplasmic Reticulum Degradation of the Transmembrane Domain of the Amyloid Precursor Protein

Bunnell, W. L., Pham, H. V., & Glabe, C. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31947 · Cited by 37

Beta amyloid is neurotoxic in hippocampal slice cultures

Harrigan, M. R., Kunkel, D. D., Nguyen, L. B., & Malouf, A. T. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00095-v · Cited by 37

Systematic Aβ Analysis in Drosophila Reveals High Toxicity for the 1-42, 3-42 and 11-42 Peptides, and Emphasizes N- and C-Terminal Residues

Jonson, M., Pokrzywa, M., Starkenberg, A., Hammarström, P., & Thor, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133272 · Cited by 35

Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism

Masilamoni, J. G., Philip, J. E., Ashok, B. S., Kirubagaran, R., Walter, C. E. J., Dicky John Davis, G., Vignesh, S., Dhandayuthapani, S., & Rajadas, J. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.05.011 · Cited by 36

Exploring amyloid oligomers with peptide model systems

Samdin, T. D., Kreutzer, A. G., & Nowick, J. S. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.05.004 · Cited by 37

A potential therapeutic effect of saikosaponin C as a novel dual‐target anti‐Alzheimer agent

Lee, T. H., Park, S., You, M., Lim, J.-H., Min, S., & Kim, B. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13515 · Cited by 37

Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation?

Glabe, C. G. (2000) · Nature Medicine · doi:10.1038/72215 · Cited by 37

The Functions of the Amyloid Precursor Protein Gene

Panegyres, P. K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.1 · Cited by 36

An introduction to electrospray ionization and matrix‐assisted laser desorption/ionization mass spectrometry: Essential tools in a modern biotechnology environment

Hop, C. E. C. A., & Bakhtiar, R. (1997) · Biospectroscopy · doi:10.1002/(sici)1520-6343(1997)3:4 · Cited by 36

Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease

Lee, J., Kweon, H., Cho, E., Lee, J.-Y., Byun, H.-R., Kim, D. H., Kim, Y. H., Han, P., & Koh, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.037 · Cited by 36

The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer s disease

Potter, H. (1998) · Frontiers in bioscience · doi:10.2741/a290 · Cited by 35

Coagulation Factor XIa Cleaves the RHDS Sequence and Abolishes the Cell Adhesive Properties of the Amyloid β-Protein

Saporito-Irwin, S. M., & Nostrand, W. E. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26265 · Cited by 34

Specific Modulation of the Fusogenic Properties of the Alzheimer β‐Amyloid Peptide by Apolipoprotein E Isoforms

Pillot, T., Goethals, M., Vanloo, B., Lins, L., Brasseur, R., Vandekerckhove, J. S., & Rosseneu, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00650.x · Cited by 35

GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease

Bozoyan, L., Audoy-Rémus, J., Dumas, A., Filali, M., Lacroix, S., Rivest, S., Tremblay, M., & Vallières, L. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.351 · Cited by 36

Alterations of Golgi organization in Alzheimer’s disease: A cause or a consequence?

Ayala, I., & Colanzi, A. (2016) · Tissue and Cell · doi:10.1016/j.tice.2016.11.007 · Cited by 34

The Mitochondrial Secret(ase) of Alzheimer's Disease

Young, K. J., & Bennett, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100360 · Cited by 34

Myelin Basic Protein Binds to and Inhibits the Fibrillar Assembly of Aβ42 in Vitro

Hoos, M. D., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2009) · Biochemistry · doi:10.1021/bi900037s · Cited by 37

Amyloids: The History of Toxicity and Functionality

Yakupova, E. I., Bobyleva, L. G., Shumeyko, S. A., Vikhlyantsev, I. M., & Bobylev, A. G. (2021) · Biology · doi:10.3390/biology10050394 · Cited by 34

Emerging evidence for the neuroprotective role of α-synuclein

Lee, H., Zhu, X., Takeda, A., Perry, G. L., & Smith, M. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.024 · Cited by 37

Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17–21 for the oligomerization state and bioactivity of hCt

Kazantzis, A., Waldner, M., Taylor, J. W., & Kapurniotu, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02689.x · Cited by 33

Elevated Aβ levels in Alzheimer's disease brain are associated with selective accumulation of Aβ42 in parenchymal amyloid plaques and both Aβ40 and Aβ42 in cerebrovascular deposits

Savage, M. J., Kawooya, J. K., Pinsker, L. R., Emmons, T. L., Mistretta, S., Siman, R. G., & Greenberg, B. (1995) · Amyloid · doi:10.3109/13506129508999005 · Cited by 33

Suppression of an amyloid β-peptidemediated calcium channel response by a secreted β-amyloid precursor protein

Li, W., Butler, J. P., Hale, J. E., McClure, D., Little, S. H., Czilli, D. L., & Simmons, L. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00479-0 · Cited by 33

Alzheimer's Disease-Linked Mutation of Presenilin 2 (N141I-PS2) Drastically Lowers APPα Secretion: Control by the Proteasome

Marambaud, P., da Costa, C. A., Ancolio, K., & Checler, F. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9619 · Cited by 33

Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration

Griffin, E. F., Yan, X., Caldwell, K. A., & Caldwell, G. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy308 · Cited by 34

Three Decades of Amyloid Beta Synthesis: Challenges and Advances

Kasim, J. K., Kavianinia, I., Harris, P. W. R., & Brimble, M. A. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00472 · Cited by 32

Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): A review of the variety in phenotypic expression

Bornebroek, M., Haan, J., & Roos, R. A. C. (1999) · Amyloid · doi:10.3109/13506129909007331 · Cited by 32

Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer’s disease

Gandy, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00125-2 · Cited by 32

Cultured cell and transgenic mouse models for tau pathology linked to β-amyloid

Bloom, G. S., Ren, K., & Glabe, C. G. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.008 · Cited by 32

The heat shock/oxidative stress connection

Pappolla, M. A., Sos, M., Omar, R. A., & Sambamurti, K. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815201 · Cited by 32

Laser-Induced Liquid Bead Ion Desorption Mass Spectrometry: An Approach to Precisely Monitor the Oligomerization of the β-Amyloid Peptide

Cernescu, M., Stark, T., Kalden, E., Kurz, C., Leuner, K., Deller, T., Göbel, M., Eckert, G. P., & Brutschy, B. (2012) · Analytical Chemistry · doi:10.1021/ac300258m · Cited by 30

Amyloid β protein enhances the clearance of extracellular l-glutamate by cultured rat cortical astrocytes

Abe, K., & Misawa, M. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00190-6 · Cited by 31

Structural analysis of amyloid β peptide fragment (25–35) in different microenvironments

Shanmugam, G., & Rajadas, J. (2004) · Biopolymers · doi:10.1002/bip.20131 · Cited by 31

The influence of the central region containing residues 19−25 on the aggregation properties and secondary structure of Alzheimer's β‐amyloid peptide

El‐Agnaf, O. M. A., Guthrie, D. J. S., Walsh, D. M., & Irvine, G. B. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2560560.x · Cited by 31

The molecular genetics of Alzheimer's disease

MULLAN, M. J., & Crawford, F. (1994) · Molecular Neurobiology · doi:10.1007/bf02816100 · Cited by 32

Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease

Ganeshpurkar, A., Swetha, R., Kumar, D., Gangaram, G. P., Singh, R., Gutti, G., Jana, S., Kumar, D., Kumar, A., & Singh, S. K. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190304153353 · Cited by 30

Peptide design through binding interface mimicry with PepMimic

(2025) · doi:10.1038/s41551-025-01507-4 · Cited by 30

Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease

Mezeiová, E., Chalupova, K., Nepovimová, E., Górecki, L., Prchal, L., Maliňák, D., Kuča, K., Soukup, O., & Korábečný, J. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228122956 · Cited by 31

Engineered Saccharomyces cerevisiae strain for improved xylose utilization with a three-plasmid SUMO yeast expression system

Hughes, S. R., Sterner, D. E., Bischoff, K. M., Hector, R. E., Dowd, P. F., Qureshi, N., Bang, S. S., Grynaviski, N., Chakrabarty, T., Johnson, E. T., et al. (2008) · Plasmid · doi:10.1016/j.plasmid.2008.09.001 · Cited by 30

Sigma-1 (σ1) receptor deficiency reduces β-amyloid25–35-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B

Yin, J., Sha, S., Chen, T., Wang, C., Hong, J., Jie, P., Zhou, R., Li, L., Sokabe, M., & Chen, L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.027 · Cited by 30

Inhibition of Familial Cerebral Amyloid Angiopathy Mutant Amyloid β-Protein Fibril Assembly by Myelin Basic Protein

Hoos, M. D., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m603494200 · Cited by 30

Detection of β-Amyloid Peptide Aggregation Using DNA Electrophoresis

Ahn, B. W., Song, D. U., Jung, Y. D., Chay, K.-O., Chung, M. A., Yang, S. Y., & Shin, B. A. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4719 · Cited by 30

Histidine residues underlie Congo red binding to Aβ analogs

Inouye, H., Nguyen, J. T., Fraser, P. E., Shinchuk, L. M., Packard, A. B., & Kirschner, D. A. (2000) · Amyloid · doi:10.3109/13506120009146832 · Cited by 31

Cellular and molecular basis of beta-amyloid precursor protein metabolism

Xu, H. (1998) · Frontiers in bioscience · doi:10.2741/a283 · Cited by 30

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics

Ritter, A. R., & Cummings, J. L. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00186 · Cited by 29

Immunoreactivity of Phage Library-derived Human Single-Chain Antibodies to Amyloid Beta Conformers In Vitro

Yoshihara, T., Takiguchi, S., Kyuno, A., Tanaka, K., Kuba, S., Hashiguchi, S., Ito, Y., Hashimoto, T., Iwatsubo, T., Tsuyama, S., et al. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm239 · Cited by 29

CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice

Yin, K., Jin, J., Zhu, X., Yu, L., Wang, S., Qian, L., Han, L., & Xu, Y. (2017) · Neurological Research · doi:10.1080/01616412.2017.1348689 · Cited by 30

N-terminal Domain of Myelin Basic Protein Inhibits Amyloid β-Protein Fibril Assembly

Liao, M.-C., Hoos, M. D., Aucoin, D., Ahmed, M., Davis, J., Smith, S. O., & Nostrand, W. E. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169599 · Cited by 29

Improved preparation of β-amyloid(1–43): structural insight leading to optimised positioning of N-(2-hydroxy-4-methoxybenzyl)(Hmb) backbone amide protection

Quibell, M., Turnell, W. G., & Johnson, T. (1995) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19950002019 · Cited by 29

Effect of chloroquine and leupeptin on intracellular accumulation of amyloid‐beta (Aβ) 1–42 peptide in a murine N9 microglial cell line

Chu, T., Tran, T., Yang, F., Beech, W. K., Cole, G. M., & Frautschy, S. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01161-2 · Cited by 29

Amyloid formation by salmon calcitonin

Gilchrist, P. J., & Bradshaw, J. P. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90160-3 · Cited by 29

Transgenic models of neurodegenerative diseases

Lee, M. K., Borchelt, D., Wong, P. C., Sisodia, S. S., & Price, D. L. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80099-7 · Cited by 29

Aβ42 oligomers modulate β-secretase through an XBP-1s-dependent pathway involving HRD1

Gerakis, Y., Dunys, J., Bauer, C., & Checler, F. (2016) · Scientific Reports · doi:10.1038/srep37436 · Cited by 30

[33] Analysis of amyloid-β assemblies using tapping mode atomic force microscopy under ambient conditions

Ding, T. T., & Harper, J. D. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09035-7 · Cited by 28

Reduced neuronal expression of synaptic transmission modulator HNK‐1/neural cell adhesion molecule as a potential consequence of amyloid β‐mediated oxidative stress: a proteomic approach

Thomas, S. N., Soreghan, B. A., Nistor, M., Sarsoza, F. M., Head, E., & Yang, A. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02892.x · Cited by 29

Dorothy Russell Memorial Lecture The molecular pathology of Alzheimer's disease: are we any closer to understanding the neurodegenerative process?

Smith, C. J., & Anderton, B. H. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00977.x · Cited by 27

Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques.

Prior, R., D’Urso, D., Frank, R. W., Prikulis, I., Cleven, S., Ihl, R., & Pavlaković, G. (1996) · Europe PMC (PubMed Central) · Cited by 28

Effects of curcumin on hippocampal expression of NgR and axonal regeneration in Aβ-induced cognitive disorder rats

Yin, H. L., Wang, Y. L., Li, J. F., Han, B., Zhang, X. X., Wang, Y. T., & Geng, S. (2014) · Genetics and Molecular Research · doi:10.4238/2014.march.24.8 · Cited by 27

The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin

Cao, Q., Anderson, D. H., Liang, W. Y., Chou, J., & Saelices, L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013440 · Cited by 27

Effects of altered RTN3 expression on BACE1 activity and Alzheimer’s neuritic plaques

Sharoar, M. G., & Yan, R. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0054 · Cited by 28

Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

Hilbich, C., Kisters–Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. T. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580

Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.

Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16256.x · Cited by 82

Amyloid βA4 of Alzheimer’s Disease: Structural Requirements for Folding and Aggregation

Hilbich, C., Kisters–Woike, B., Masters, C. L., & Beyreuther, K. T. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_3 · Cited by 2

Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease

Barrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 644

Structural Determinants of the Alzheimer's Amyloid β‐Peptide

Soto, C. A., Brañes, M. C., Alvarez, J., & Inestrosa, N. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63041191.x · Cited by 153